Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation

Next Previous
Trial Profile

Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Sep 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Eltrombopag (Primary)
  • Indications Thrombocytopenia
  • Focus Therapeutic Use

    • Most Recent Events

    • 01 Nov 2021 Results (n=12) from NCT01757145 and NCT01940562 whehter Eltrombopag enhances platelet engraftment in adult and pediatric patients undergoing allogeneic cord blood transplantation, published in the Leukemia and Lymphoma
    • 04 Dec 2018 Results (n=12) from NCT01757145, NCT01940562 , in both adults and children hypothesizing that eltrombopag would enhance platelet engraftment after UCB transplantation presented at the 60th Annual Meeting and Exposition of the American Society of Hematology.
    • 15 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrilas.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top